McGann M, Sacco A, Barnachea L. Evaluation of Extended-Release Oxycodone Administered through Enteral Tubes for the Management of Pain in Patients with Head and Neck Cancer: A Case Series [published online ahead of print, 2021 Sep 10]. J Pain Palliat Care Pharmacother. 2021;1-6. doi:10.1080/15360288.2020.1830224

Green JL, Robbins RS, Dailey-Govoni T, Butler SF. Nonmedical Use of Xtampza® ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-World Data from the Addiction Severity Index-Multimedia Version (ASI-MV®). J Pain Res. 2021;14:1773-1783. Published 2021 Jun 15. doi:10.2147/JPR.S304805

Markman J, Meske DS, Kopecky EA, Vaughn B, O’Connor ML, Passik SD. Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone. J Pain Res. 2018;11:2051?2059. Published 2018 Sep 26. doi:10.2147/JPR.S168836